Improvement of acquired partial lipodystrophy with rosiglitazone despite ongoing complement activation.
Walker
U A
UA
Kirschfink
M
M
Peter
H H
HH
D000328:Adult; D000886:Anthropometry; D003167:Complement Activation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008060:Lipodystrophy / Q000188:drug therapy*; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists; D000077154:Rosiglitazone; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000819:agonists
D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; D000077154:Rosiglitazone